Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02595463 · ClinicalTrials.gov registry record · Phase 2
Intravenous Lidocaine for Post-Tonsillectomy Pain in Pediatric Patients
A Phase 2 study, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Completed
- Registry status
- Phase 2
- Development phase
- 89
- Enrollment target
NCT02595463 is a Phase 2 study that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 89 participants.
The verdict
NCT02595463, a Phase 2 study, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 89 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether giving lidocaine intravenously during and after a tonsillectomy surgery is effective in decreasing postoperative pain.
Interventions
- DRUG Saline
- DRUG Lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2015-11 |
| Est. Completion | 2024-07-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02595463
The ClinicalTrials.gov registry entry for NCT02595463 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT02595463 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02595463 about?
NCT02595463 is a clinical study titled "Intravenous Lidocaine for Post-Tonsillectomy Pain in Pediatric Patients". The purpose of this study is to determine whether giving lidocaine intravenously during and after a tonsillectomy surgery is effective in decreasing postoperative pain.
What is the current status of trial NCT02595463?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 89 participants. The study started on 2015-11. Estimated completion is 2024-07-05.
What interventions are being tested in trial NCT02595463?
The interventions under investigation include: Saline (DRUG), Lidocaine (DRUG).
Who is sponsoring clinical trial NCT02595463?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.